AMPH vs DVA · P/E 12, rev $732.0M vs P/E 14, rev $12.82B
Amphastar P (AMPH) versus DaVita HealthCare Partners Inc (DVA) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Not investment advice. Open the AMPH and DVA stock pages for the full models.
Not investment advice.